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Comparison of the HbH inclusion test and a
PCR test in routine screening for ci thalassaemia
in Hong Kong
A Y Y Chan, C K C So, L C Chan
Abstract
Aim-To compare the haemoglobin (Hb)
H inclusion test with a polymerase chain
reaction (PCR) test in routine screening
for a thalassaemia.
Methods-Ninety nine peripheral blood
samples from Chinese patients with mean
corpuscular volume below 80 fl were
screened for a thalassaemia using the HbH
inclusion test andbyPCR utilising primers
bridging the common deletion breakpoint
ofthe South East Asian (--SEAl) deletion.
Results-The HbH inclusion test was pos-
itive in 78 (79%) patients, 73 (93 7%) of
whom carried the (--SEAl) deletion on
analysis of their DNA by PCR, as did one
patient with a negative HbH inclusion test.
Conclusions-These results suggest that
in areas with a high prevalence of the
(--SEAl) deletion, such as Hong Kong, the
HbH inclusion test can be replaced byPCR
as the investigation of choice in screening
for a thalassaemia.
(J7 Clin Pathol 1996;49:411-413)
Keywords: thalassaemia, (--SEA!) deletion, HbH in-
clusion test, PCR.
to the deletion breakpoint.2 This method is
highly sensitive and specific but is labour
intensive, time consuming and radioactive iso-
topes are usually needed.
A polymerase chain reaction (PCR) based
protocol which specifically detects the --SEA/
deletion is a possible alternative to Southern
blotting.5 The possibility of applying this PCR
based method in routine screening for ct thal-
assaemia was investigated.
Methods
Peripheral blood samples from 99 patients with
relevent clinical history and microcytic (mean
corpuscular volume (MCV) <80 fl) and hy-
pochromic indexes underwent the following
investigations: (1) estimation ofHbA2 and HbF
concentrations by the Variant Hemoglobin
Testing System (BioRad Laboratories, Her-
cules, California, USA). The normal adult ref-
erence range for HbA2 is 2 3-3-0% and for
HbF is 0-0 9% (unpublished data); (2) the
HbH inclusion test; and (3) electrophoresis of
haemolysate in cellulose acetate at pH 8-55
using the SuperZ kit Hb system, as appropriate.
Haematology Section,
Department of
Pathology,
The University of
Hong Kong,
Hong Kong
Correspondence to:
Dr L C Chan,
Department of Pathology,
Queen Mary Hospital,
Hong Kong.
Accepted for publication
31 January 1996
In South East Asia, oa thalassaemia is the most
common haemoglobin disorder and is char-
acterised by the absence or reduced synthesis
of oc globin chains.' In Hong Kong, the pre-
valence of ct thalassaemia is 4%.2
The HbH inclusion test, based on incubation
of erythrocytes with brilliant cresyl blue, is used
extensively in screening for subjects with ci
thalassaemia. However, it is quite laborious to
scan for HbH granules and faulty incubation
of erythrocytes may give rise to false positive
results. In addition, the HbH inclusion test
cannot be used to distinguish the two oc thal-
assaemia 1 genotypes, heterozygous ct thal-
assaemia 1 (cc/--) and homozygous ct
thalassaemia 2 (c-/oc-) .34 This distinction is vital
as couples heterozygous for ct thalassaemia 1
are at risk of producing fetuses with hydrops
fetalis due to Hb Barts and need to be identified
for genetic counselling and prenatal diagnosis.
In South East Asians ct thalassaemia 1 is
mainly caused by the South East Asian
(--SEA/) deletion.' This deletion involves the
removal of about 20-5 kilobases of DNA, in-
cluding the (poc2, (pocl, cx2, ocl, and 01 globin
genes and spares the 42 and (ptl globin genes.
The (--SEA!) deletion is usually detected by
Southern blot hybridisation with a probe close
HBH INCLUSION TEST
Air dried, peripheral blood smears were pre-
pared from a mixture of one part whole blood
to two parts 1% brilliant cresyl blue following
incubation at 37°C for exactly 30 minutes. For
detection of inclusions, 1000 to 5000 red blood
cells were examined under an oil immersion
lens. Microscopic examination took up to 15
minutes per case.
As the iron status of the patients was not
available, the exclusion of typical iron deficient
samples was based on the red blood cell in-
dexes, a Technicon H* 1 erythrogram, the hy-
pochromia minus microcytosis (H - M) index,
and the discriminant function (DF), as de-
scribed previously.6
EXTRACTION OF DNA
DNA was extracted from peripheral blood
samples using a commercial kit (Intragene Puri-
fication Matrix, BioRad Laboratories). Red
cells were lysed by mixing 6 ml whole blood
with 1 ml water. The samples were incubated
at room temperature for 15 minutes and cent-
rifuged at 10000 rpm for three minutes; the
supernatant was then removed. Intragene mat-
rix (200 gl) was added to the pellet and the
mixture was incubated at 56°C for 30 minutes.
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Figure 1 Locationi of the (--SEAI) deletion with respect to the Y globin gene loci.
The resuspended pellet was vortexed and cent-
rifuged as recommended by the manufacturer,
and 20 .tl of the resulting supernatant was used
per 50 pl PCR reaction.
PCR CONDITIONS
Preparation ofprimers
To detect the (--SEA/) deletion, three primers
were synthesised using details of the sequences
provided by Chang et a15: S1: 5'-GCGAT-
CTGGGCTCTGTGTTCT-3'; S2: 5'-GT-
TCCCTGAGCCCCGACACG-3'; and S3:
5'-ACTGCAGCCTTGAACTCCTG-3'. Si
corresponds to nucleotides 120 to 140 located
5' to the (--SEA/) deletion. S2 corresponds to
nucleotides 293 to 314 located 3' to the first
base of the SI primer. S3 corresponds to nuc-
leotides 35 to 54 located 3' to the deletion
breakpoint. Primers Si and S2 amplify a 314
nucleotide band if normal or if oi thalassaemia
2 is present; ct thalassaemia 1 with the (--SEA/)
genotype yields a 196 nucleotide band on am-
plification with primers S1 and S3. The latter
primer pair does not amplify the normal se-
quence as they are located too far from each
other to generate a PCR product.5 Figure 1
illustrates the locations of the three primers
and the breakpoints of the (--SEA/) deletion.
PCR protocol
To amplify DNA from normal subjects or those
with ox thalassaemia 2, the PCR reaction mix-
ture comprised 10 mM Tris (pH 9 0), 50mM
KC1, 200 mM dNTPs, 1-5 mM MgCl2,
10 pmol each of primers S1 and S2, 20 ,tl
DNA, and 1 unit Taq DNA polymerase (Gibco
BRL). To detect the (--SEA/) deletion, the
concentration of MgCl2 was 1 -25 mM (optimal
concentration established in preliminary stud-
ies) and the S2 primer was replaced by S3.
DNA from patients with HbH disease served
as a control.
PCR was carried out in an automated thermo-
cycler under the following conditions: de-
naturation at 94°C for 30 seconds, annealing
at 58°C for 45 seconds, and extension at 72°C
for one minute, except for the first cycle when
denaturation took place at 95°C for 90 seconds
and at 94°C for 30 seconds, the annealing time
was 45 seconds and the extension time was
one minute.
Following amplification, 20 itl of the PCR
product was electrophoresed in a 2% agarose
gel at 100 V for one hour, stained with ethidium
bromide and visualised under ultraviolet light
(280 nm).
Results
Table 1 summarises the patients' haemato-
logical data. The HbH inclusion test was pos-
itive in 78 patients, four of whom had HbH
disease, with HbH inclusions observed in 10%
to 79% of red blood cells. Occasional HbH
inclusions were found in the remaining 74
patients, who were diagnosed as having oc thal-
assaemia trait. Four of these 74 patients also
had raised HbA2 concentrations (4-8-5 9%)
and hence were diagnosed as having o4p thal-
assaemia.
Of the 78 patients with a positive HbH in-
clusion test, 73 were heterozygous for the
(--SEA/) deletion, including one patient with
ac3 thalassaemia. On PCR, the 314 and 195
base pair (bp) fragments (fig 2, lanes a and b)
were amplified in subjects carrying the (--SEA!)
deletion. The 314 bp fragment only was amp-
lified in those not carrying the deletion. The
Table 1 Summary of the haematological data of the 99 patients studied
RBC indexes
No. of HbH inclusion Haenmoglobin RBC
samples Diagnosis bodies HbA, count (x 1012 /1) MCV(fl) MCH(pg) RDW(%.) H-Ma DF5
70 o-thalassaemia Occasional N 11-5 5 40 68-8 21-4 15-7 +7.7c -9 01
(7-3-14-7) (3-51-7-17) (56-5-76-1) (18-1-25-5) (13-7-27-5)
4 op-thalassaemia Occasional T 10-6 5-16 66-8 20-5 14-9 -8-3d - 14 4'(8-2-13-1) (4-29-6-51) (63 5-72-5) (19-1-22-1) (14-9-15 2)
4 HbH disease 10-79' N 9-8 5 30 68-3 18-6 20-2 +28-5 -5-3
(8-6-10-5) (5-12-5-58) (62 2-74 0) (16-8-19-7) (19-3-21-0)
21 No abnormal None N 11 1 4-79 74-3 23-1 16-2 +151 -4-9
haemoglobin (7-9-16-6) (3-71-7-44) (68 3-79-9) (19 9-27 5) (12-9-22-5)
aHypochromia minus microcytosis (H-M) index.
b Discriminant function (DF) was calculated from the formula MCV -RBC -(5 x Hb) -19-2.
'Result was calculated from 14 samples only.
Result was calculated from three samples only.
'Result was calculated from 20 samples only.
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Figure 2 Ethidium bromide stained agarose gel of amplified DNA from two patie
(1 and 2; lanes a and b, and c and d, respectively) with positive HbH inclusion t4
DNA fragment sizes are given in base pairs (bp). Lanes a and c, SIIS2 primer pt
lanes b and d, SIIS3 primer pair; lane M, bluescript marker. Patient 1 is heterozy
for the (--SEAI) deletion; patient 2 does not carry the (--SEAI) deletion.
(--SEA!) deletion was not detected in five
patients with a positive HbH inclusion test
(fig 2, lanes c and d), three of whom had
thalassaemia, one had iron deficiency anaemia
and the other had unexplained hypochromic
microcytic anaemia with no family history of
thalassaemia.
Of the 21 patients with a negative HbH
inclusion test, one was found to have the
(--SEA!) deletion on PCR. The frequency of
occurrence of this event was 1-3% (1/79).
The frequency of ot thalassaemia due to the
(--SEA!) deletion was 93*7% (74/79).
Discussion
The (--SEA!) deletion was the most common
cause of cx thalassaemia in the present study
with a carrier frequency of 93-7% (74/79).
Very similar results were reported in Taiwan
by Tsang et al.7
Of the 73 patients with a positive HbH in-
clusion test, five were not carrying the (--SEA!)
deletion. The HbH inclusion tests in these
five patients may have been falsely positive.
Alternatively, the patients may be carriers of
another oa thalassaemia determinant, such as
(--Fil/), (--Thai/), or (--HW/), which have also
been reported in South East Asians.89 Another
other possible explanation is that they are
homozygous for the a thalassaemia 2 deter-
minant (a-/o-). The -ca3-7 and -ot4-2 deletions
are the most common deletional forms of a
thalassaemia 2 found in South East Asia.'0
Other less common deletional forms of ot thal-
assaemia 2, such as -c2-7, are also present in
this region" as are the non-deletional forms of
cx thalassaemia 2, such as cxcxCS and CaQS."' 12
In the few patients with a negative result on
PCR, but who have a revelent clinical history
and microcytic and hypochromic indexes, fur-
ther DNA analysis should be carried out to
avoid missing the oa thalassaemia genotypes that
can potentially produce hydrops fetalis.
Interestingly, three of four patients with o43
thalassaemia did not carry the (-SEA/) deletion.
As the carrier frequency of the this deletion in
patients with o43 thalassaemia is about 25%
(one in four), several o4p samples should be
tested to exclude sample bias.
Unlike the HbH inclusion test, which is time
consuming and labour intensive, PCR can be
performed in batches. Excluding staff and ini-
tial equipment costs, the cost per sample is
HK$50 (L4.00), which is reasonable given that
a definitive diagnosis of cx thalassaemia can be
made. The test is rapid and simple and the
genotypes of the patients can be easily de-
termined from the ethidium bromide stained
amplified DNA fragments. The PCR data can
be used for prenatal counselling of couples at
risk.
In a previous study'3 we showed that im-
munocytochemical detection of embryonic 4
chain, a specific marker for a thalassaemia 1 is
also superior to the HbH inclusion test in the
routine screening of a thalassaemia. Further
studies comparing the immunocytochemical
test with the PCR based protocol should be
carried out to ascertain the definitive screening
test for a thalassaemia 1 in high prevalence
areas.
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